Health care costs of persons with newly diagnosed hepatitis C virus: a population-based, observational study

Thu-Ha Nguyen1, Philip Jacobs, Anita Hanrahan

  • 1Public Health Division, Alberta Health and Wellness, University of Alberta, Edmonton, Alberta, Canada.

Insights

Hepatitis C diagnosis leads to increased healthcare costs, primarily driven by mental health services, not just liver-related expenses. Understanding the full cost picture is crucial for effective patient management.

Area of Science:

  • Health Economics
  • Hepatology
  • Public Health

Background:

  • Hepatitis C virus (HCV) infection poses a significant global health burden.
  • Previous cost analyses for hepatitis C often focused narrowly on liver-related medical expenses.
  • A comprehensive understanding of the total healthcare service costs associated with hepatitis C is needed.

Purpose of the Study:

  • To analyze the health services costs for individuals diagnosed with hepatitis C.
  • To compare costs in the pre-diagnosis year and two years post-diagnosis.
  • To identify the primary cost drivers beyond direct liver-related care.

Main Methods:

  • Retrospective analysis of healthcare utilization and costs.
  • Data linkage of 1230 individuals diagnosed with hepatitis C in Alberta, Canada (1998).
  • Inclusion of physician visits, hospital inpatient, and outpatient records for cost assignment.

Main Results:

  • Total per-person costs rose from $2630 (pre-diagnosis) to $3514 (first post-diagnosis year), then decreased to $2694 (second post-diagnosis year).
  • Liver-related costs constituted a small portion of total expenses, despite increasing post-diagnosis.
  • Mental health services represented the largest component of healthcare costs for this cohort.

Conclusions:

  • Healthcare costs for individuals with hepatitis C extend significantly beyond liver-specific treatments.
  • Mental health services are a major contributor to the overall economic burden of hepatitis C.
  • A holistic approach considering all health services is essential for accurate hepatitis C cost assessment.

Related Concept Videos

Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...
Cytomegalovirus Disease01:27

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...